ADI1 and prostate carcinoma: In leukemia cells, Apl-1 did not cause any significant changes in the expression of Hsp90 proteins, while in prostate cancer cells, at a concentration of 3.2 μM it inhibited the expression of Hsp90 proteins (Figure 6c and Figure S5).